Speaker(s): 

Ryan McLay, BSc, PharmD Candidate, Geisinger - has nothing to disclose.

Kieran Burrier, PharmD Candidate, Geisinger - has nothing to disclose.

Madison Gordon, PharmD Candidate, Geisinger - has nothing to disclose.

Moderator(s): 

Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Review intra renal conditions caused by renal toxic medications
2. Discuss the most common medications that cause intra renal toxicity seen in the inpatient setting
3. Assess treatment options to mitigate renal toxicity

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None